Skip to content

Category: Phase 1 Clinical Trial

First human gets new antibody aimed at hepatitis C virus

August 6, 2009 by srrpenna

Phase 1 clinical trial in healthy subjects designed to advance novel treatment to prevent Hep C

Boston, Mass. — Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).

AdaptiveThemes